These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3828102)

  • 1. Urinary and biliary excretion kinetics of ketamine and its metabolites in the rabbit.
    Pedraz JL; Calvo MB; Lanao JM; Dominguez-Gil A
    Boll Chim Farm; 1986 Sep; 125(9):357-61. PubMed ID: 3828102
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of ketamine and its metabolites in rabbits with normal and impaired renal function.
    Pedraz JL; Lanao JM; Dominguez-Gil A
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):33-9. PubMed ID: 4029219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biotransformation kinetics of ketamine "in vitro" in rabbit liver and lung microsome fractions.
    Pedraz JL; Lanao JM; Hernandez JM; Domínguez-Gil A
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):9-16. PubMed ID: 3720798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronidation and biliary excretion of acetaminophen in rats.
    Hjelle JJ; Klaassen CD
    J Pharmacol Exp Ther; 1984 Feb; 228(2):407-13. PubMed ID: 6694118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of biliary excretion on ketamine anaesthesia in the rat.
    Ireland SJ; Livingston A
    Br J Anaesth; 1980 Jan; 52(1):23-8. PubMed ID: 7378227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic clearance of gitoxin. Metabolism and biliary excretion by rabbit isolated liver.
    Pellegrin PL; Lesne M
    Drug Metab Dispos; 1984; 12(2):235-41. PubMed ID: 6144490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pregnenolone-16 alpha-carbonitrile on the biliary and urinary excretion of imipramine and some of its metabolites in rats.
    Brookman S; Kourounakis P
    Arzneimittelforschung; 1982; 32(10):1298-301. PubMed ID: 6891231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of halothane anesthesia on ketamine biotransformation.
    White PF; Pudwill CR; Johnston RR; Way WL; Trevor AJ; Marietta MP
    Proc West Pharmacol Soc; 1976; 19():227-31. PubMed ID: 995991
    [No Abstract]   [Full Text] [Related]  

  • 10. The urinary excretion of ketamine and its metabolites in the rat [proceedings].
    Livingston A; Waterman AE
    Br J Pharmacol; 1978 Nov; 64(3):402P. PubMed ID: 719260
    [No Abstract]   [Full Text] [Related]  

  • 11. Alteration in the biliary and urinary excretion of acetaminophen metabolites by nephrotoxicants in rats.
    Seo KW; Choung SY; Park KS; Kim HJ
    Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):305-17. PubMed ID: 9144837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
    Beach CA; Mays DC; Sterman BM; Gerber N
    J Pharmacol Exp Ther; 1985 Apr; 233(1):18-23. PubMed ID: 3981454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
    Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Parameters suitable for assessing biliary excretion of drugs.
    Sperber I; Ryrfeldt A
    Acta Pharm Suec; 1974 Dec; 11(6):650-1. PubMed ID: 1136802
    [No Abstract]   [Full Text] [Related]  

  • 16. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 3-phenoxybenzoic acid and the enterohepatorenal disposition of its metabolites in the rat.
    Huckle KR; Chipman JK; Hutson DH; Millburn P
    Drug Metab Dispos; 1981; 9(4):360-8. PubMed ID: 6114836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, distribution, and excretion of the carcinogenic aromatic amine, 3,3'-dimethoxybenzidine in the rat. Formation of mutagenic urinary and biliary metabolites.
    Rodgers RM; Garvie-Gould C; Scott KF; Milam DF; Lynn RK
    Drug Metab Dispos; 1983; 11(4):293-300. PubMed ID: 6137333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of spironolactone pretreatment on the biliary excretion of digitoxin and its metabolites in male and female rats.
    Kitani K; Sato Y; Kanai S; Nokubo M
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):355-73. PubMed ID: 7178649
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotransformation and excretion of methylcyclopentadienyl manganese tricarbonyl in the rat.
    Hanzlik RP; Bhatia P; Stitt R; Traiger GJ
    Drug Metab Dispos; 1980; 8(6):428-33. PubMed ID: 6109612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.